You are here

  • Home
  • Archive
  • Volume 66, Issue 7
  • Palbociclib (PD-0332991), a selective CDK4/6 inhibitor, restricts tumour growth in preclinical models of hepatocellular carcinoma

Article metrics

Article menu

Download PDFPDF

XML
Hepatology
Original article
Palbociclib (PD-0332991), a selective CDK4/6 inhibitor, restricts tumour growth in preclinical models of hepatocellular carcinoma

 

Online download statistics by month:

Online download statistics by month: November 2016 to April 2023

AbstractFullPdf
Nov 20161082652450
Dec 2016315387454
Jan 2017237281182
Feb 201753161151
Mar 20177128155
Apr 20173147154
May 201715158154
Jun 2017112525312
Jul 2017265264225
Aug 2017145142121
Sep 2017121119109
Oct 2017146141126
Nov 201714314199
Dec 201712612466
Jan 2018168179157
Feb 201815315174
Mar 201818517991
Apr 201820320376
May 201819019186
Jun 201815815880
Jul 201819118771
Aug 201812112168
Sep 201815115173
Oct 201814314389
Nov 201812812682
Dec 201812212268
Jan 201914212864
Feb 20191049443
Mar 201919417795
Apr 201919718485
May 201916815776
Jun 201916515858
Jul 201917515799
Aug 201910285106
Sep 201915313962
Oct 201914612552
Nov 201917014177
Dec 201915413267
Jan 202016313560
Feb 20201569465
Mar 20201199957
Apr 20201158957
May 202014811688
Jun 202015913176
Jul 202016312879
Aug 20201219091
Sep 2020215138121
Oct 202014413460
Nov 202015712468
Dec 202021014474
Jan 202119416869
Feb 202119214575
Mar 202121719384
Apr 202118215097
May 2021167160121
Jun 2021236236120
Jul 2021166166119
Aug 202120220278
Sep 202115915871
Oct 202116412972
Nov 2021204162115
Dec 2021182155102
Jan 2022182168127
Feb 2022186135112
Mar 2022278254151
Apr 202228527879
May 2022249201111
Jun 202219116598
Jul 202222217679
Aug 202215913677
Sep 2022199180275
Oct 202217713372
Nov 202218315066
Dec 202215312873
Jan 202318816563
Feb 202310531010151
Mar 2023224206107
Apr 202315612062
Total14773140098379